Page last updated: 2024-09-04

cgp 6809 and Neoplasms

cgp 6809 has been researched along with Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fiebig, HH; Löhr, GW; Widmer, KH; Winterhalter, BR1
Cowens, JW; Creaven, PJ; Huben, R; Karakousis, C; Petrelli, N; Traynor, D1
Cowens, JW; Creaven, PJ; Huben, R; Karakousis, C; Madajewicz, S; Mittelman, A; Pendyala, L; Petrelli, N; Plager, JE; Takita, H1

Trials

1 trial(s) available for cgp 6809 and Neoplasms

ArticleYear
Phase I clinical trial of ethyl 6-deoxy-3,5-di-O-methyl 6-(3 methyl-3-nitrosoureido)-alpha-D-glucofuranoside (CGP 6809).
    Cancer chemotherapy and pharmacology, 1987, Volume: 20, Issue:1

    Topics: Adult; Aged; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Female; Humans; Infusions, Intravenous; Kinetics; Liver Function Tests; Male; Middle Aged; Nausea; Neoplasms; Nitrosourea Compounds; Vomiting

1987

Other Studies

2 other study(ies) available for cgp 6809 and Neoplasms

ArticleYear
CGP 6809--a new nitrosoureido-sugar derivative with activity in human tumor xenografts.
    Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:6

    Topics: Animals; Antineoplastic Agents; Drug Evaluation, Preclinical; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Nitrosourea Compounds; Transplantation, Heterologous

1989
Phase I trial of a new nitrosourea, CGP 6809, given every 2 weeks.
    Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Evaluation; Drug Tolerance; Female; Humans; Male; Middle Aged; Neoplasms; Nitrosourea Compounds; Time Factors

1989